Manuel Zorzi
Screening for colorectal cancer with fecal immunochemical tests effectively detected advanced neoplasia in the distal colon and rectum, but had suboptimal performance in the proximal colon, according to findings published in Annals of Internal Medicine.
“Several studies have shown that screening for colon and rectal cancer with the fecal immunochemical test (FIT) reduces the number of deaths due to this disease,” Manuel Zorzi, MD, MSc, from Veneto Tumour Registry, Azienda Zero, Padova, Italy, told Healio Internal Medicine. “Previous studies also suggest that the

Source link